InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the detailed record of transactions filed by Meek David D., Director. Officer active across 3 companies, notably Mirati Therapeutics, Inc.. In total, 7 disclosures have been recorded. Total volume traded: €9k. The latest transaction was disclosed on 15 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations7 total
09,080 shares0
Ordinary Shares
SEC:0000904454-22-000352:0·
€8,991602 shares@ €14.9360.0006% mcap100.0% of flow
Ordinary Shares
SEC:0000904454-22-000215:0·
01,534 shares0
Ordinary Shares
SEC:0000904454-22-000193:0·
027,500 shares0
Common Stock
SEC:0001104659-22-005415:0·
027,500 shares0
Common Stock
SEC:0001104659-22-005415·
034,057 shares0
Common Stock
SEC:0001214659-22-000844·
034,057 shares0
Common Stock
SEC:0001214659-22-000844:0·
7 of 7 declarations
About Meek David D.
David D. Meek is Chief Executive Officer and Director at Mirati Therapeutics, Inc., Entasis Therapeutics Holdings Inc., and uniQure N.V. He leads these companies in developing innovative therapies for serious diseases. David uses his expertise to guide the strategy and growth of these organizations.
